Latest Ratios: P/E Ratio -0.7x · EV/EBITDA N/A · ROE -82.7%. (2019–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Market Cap | $46M | $157M | $76M | $65M | $48M | $269M | — | — |
| Enterprise Value | $8M | $119M | $-1860060 | $-40218940 | $-30800808 | $2M | — | — |
| P/E Ratio → | -0.73 | — | — | — | — | — | — | — |
| P/S Ratio | 716.90 | 2452.52 | 2.93 | — | — | — | — | — |
| P/B Ratio | 0.97 | 3.74 | 0.83 | 0.64 | 0.30 | 0.99 | — | — |
| P/FCF | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1864.16 | -0.07 | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 100.0% | 100.0% | 100.0% | — | — | — | — | — |
| Operating Margin | -90740.6% | -90740.6% | -86.2% | — | — | — | — | — |
| Net Profit Margin | -86687.5% | -86687.5% | -60.0% | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| ROE | -82.7% | -82.7% | -16.1% | -48.0% | -55.0% | -163.0% | — | — |
| ROA | -70.5% | -70.5% | -13.7% | -41.2% | -50.8% | -127.8% | -719.9% | -316.7% |
| ROIC | -472.5% | -472.5% | -323.5% | -137.7% | -214.1% | -1576.6% | — | — |
| ROCE | -85.9% | -85.9% | -23.0% | -53.0% | -55.3% | -65.9% | -191.1% | -223.5% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.90 | -0.85 | -1.04 | -0.50 | -0.98 | — | — |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — |
| Interest Coverage | — | — | — | — | -5599.66 | -29235.62 | -4708.64 | -2080.02 |
Net cash position: cash ($38M) exceeds total debt ($690000)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.74 | 3.74 | 11.46 | 4.85 | 9.97 | 15.30 | 27.81 | 13.24 |
| Quick Ratio | 3.74 | 3.74 | 11.46 | 4.85 | 9.97 | 15.30 | 27.81 | 13.24 |
| Cash Ratio | 3.26 | 3.26 | 11.07 | 4.68 | 9.76 | 14.89 | 26.93 | 12.40 |
| Asset Turnover | — | 0.00 | 0.26 | — | — | — | — | — |
| Inventory Turnover | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | 918.20 | 14.74 | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.2% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.2% | — | — |
| Shares Outstanding | — | $56M | $55M | $55M | $55M | $52M | $54M | $56M |
Includes 30+ ratios · 7 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CNTB stock.
Connect Biopharma Holdings Limited's current P/E ratio is -0.7x. This places it at the 50th percentile of its historical range.
Connect Biopharma Holdings Limited's return on equity (ROE) is -82.7%. The historical average is -72.9%.
Based on historical data, Connect Biopharma Holdings Limited is trading at a P/E of -0.7x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Connect Biopharma Holdings Limited has 100.0% gross margin and -90740.6% operating margin.